脑脊液白介素8、干扰素γ水平在结核性脑膜炎病程中的动态变化及意义
本文关键词: 结核 脑膜 白细胞介素类 干扰素γ 脑脊液 出处:《中国全科医学》2017年27期 论文类型:期刊论文
【摘要】:目的观察结核性脑膜炎(TBM)患者脑脊液白介素8(IL-8)、干扰素γ(IFN-γ)水平的动态变化情况,并探讨脑脊液IL-8、IFN-γ水平在TBM诊断和预后中的应用价值。方法选取2014年12月—2016年8月在兰州大学第二医院住院的符合纳入标准的TBM患者(作为TBM组)、病毒性脑膜炎患者(作为病毒性脑膜炎组)、非感染性神经系统疾病患者(作为非感染性神经系统疾病组),各30例。TBM组患者病情严重程度:Ⅰ期患者12例,Ⅱ期患者11例,Ⅲ期患者7例。分析TBM组患者抗结核治疗前及抗结核治疗后1、2周的脑脊液IL-8、IFN-γ水平变化,比较TBM组患者抗结核治疗前,病毒性脑膜炎组、非感染性神经系统疾病组患者治疗前脑脊液IL-8、IFN-γ水平,并分析TBM组患者脑脊液IL-8、IFN-γ水平与其病情严重程度的关系。结果 TBM组患者抗结核治疗后1周脑脊液IL-8、IFN-γ水平低于抗结核治疗前(t_(配对)=15.710,P0.001;t_(配对)=10.793,P0.001);TBM组患者抗结核治疗后2周脑脊液IL-8、IFN-γ水平低于抗结核治疗前(t_(配对)=21.268,P0.001;t_(配对)=14.357,P0.001);TBM组患者抗结核治疗后2周脑脊液IL-8、IFN-γ水平低于抗结核治疗后1周(t_(配对)=12.554,P0.001;t_(配对)=17.979,P0.001)。TBM组患者抗结核治疗前脑脊液IL-8、IFN-γ水平高于病毒性脑膜炎组、非感染性神经系统疾病组患者治疗前(P0.05);病毒性脑膜炎组患者治疗前脑脊液IL-8、IFN-γ水平高于非感染性神经系统疾病组患者治疗前(P0.05)。TBM组患者脑脊液IL-8、IFN-γ水平与其病情严重程度呈正相关(rs值分别为0.509、0.665,P值分别为0.004、0.001)。结论抗结核治疗后TBM患者脑脊液IL-8、IFN-γ水平逐渐下降,且脑脊液IL-8、IFN-γ水平与病情严重程度呈正相关,说明脑脊液IL-8、IFN-γ水平对TBM有一定的诊断价值,可用于患者的治疗效果评估及预后判断。
[Abstract]:Objective to observe the dynamic changes of interleukin-8 (IL-8) and interferon 纬 (IFN- 纬) levels in cerebrospinal fluid (CSF) of patients with tuberculous meningitis (TBM). To explore the clinical value of IL-8 IFN- 纬 level in the diagnosis and prognosis of TBM methods TBM patients who were hospitalized in the second Hospital of Lanzhou University from December 2014 to August 2016 (as TBM group, viral meningitis) were selected. Patients with viral meningitis, patients with non-infectious nervous system diseases (30 patients with non-infectious nervous system diseases, 30 patients with TBM), 12 patients with stage I patients, The levels of IL-8 IFN- 纬 in cerebrospinal fluid (CSF) of TBM patients before and after antituberculous therapy were analyzed, and the changes of IL-8 IFN- 纬 levels in TBM patients before and after anti-tuberculosis therapy were compared. The level of IL-8 and IFN- 纬 in cerebrospinal fluid (CSF) of patients with non-infectious nervous system diseases before treatment, The relationship between the level of IL-8 IFN- 纬 in cerebrospinal fluid (CSF) and the severity of the disease in TBM group was analyzed. Results the level of IL-8 IFN- 纬 in cerebrospinal fluid in TBM group was lower than that in SARS group before anti-tuberculosis treatment. The level of IL-8 IFN- 纬 in cerebrospinal fluid (CSF) 2 weeks after antituberculous treatment was lower than that in the anti-tuberculosis treatment group (P 0.001). The level of IL-8 IFN- 纬 in cerebrospinal fluid (CSF) 2 weeks after anti-tuberculosis treatment in TBM group was lower than that in the control group (12.554% P 0.001 ~ (-1) t) after antituberculous treatment (P 0.001 ~ (-1) TBM group.) the level of IL-8IFN- 纬 in cerebrospinal fluid (IL-8IFN- 纬) before anti-tuberculosis treatment in TBM group was lower than that in anti-tuberculosis treatment group (P < 0.01). The level of IL-8IFN- 纬 in cerebrospinal fluid before anti-tuberculosis treatment was lower than that in TBM group. The level of viral meningitis was higher than that of viral meningitis. The level of IL-8 IFN- 纬 in cerebrospinal fluid of patients with viral meningitis before treatment was higher than that of patients with non-infectious neurological diseases before treatment (P0.05. TBM), and the level of IL-8 IFN- 纬 in cerebrospinal fluid of patients with viral meningitis was higher than that of patients with non-infectious neurological diseases before treatment. The positive correlation values of rs were 0.509 ~ 0.665U P = 0.004 ~ 0.0010.Conclusion the levels of IL-8 and IFN- 纬 in cerebrospinal fluid (CSF) of TBM patients decreased gradually after anti-tuberculosis treatment. The level of IFN- 纬 in CSF was positively correlated with the severity of the disease, which indicated that the level of IL-8 IFN- 纬 in CSF had a certain diagnostic value for TBM, and could be used to evaluate the therapeutic effect and to judge the prognosis of the patients.
【作者单位】: 兰州大学第二医院神经内科;
【基金】:甘肃省兰州市城关区科技发展计划项目(2015-3-3)
【分类号】:R529.3
【相似文献】
相关期刊论文 前10条
1 关玉娟,陈青锋,冼建中,肖萍;干扰素γ治疗慢性乙型肝炎肝纤维化的临床研究[J];中华内科杂志;2003年07期
2 王秀霞;;干扰素γ辅助治疗肺结核的临床研究[J];临床误诊误治;2010年S2期
3 张文瑾,辛绍杰,靳雪源,陈国风;干扰素γ治疗慢性乙型肝炎肝纤维化的临床观察[J];第二军医大学学报;2003年10期
4 张平安;吴健民;李艳;;干扰素γ基因内含子1+874位点多态性与乙型肝炎病毒感染关系的研究[J];中华流行病学杂志;2006年01期
5 郭晓东;熊璐;李小溪;刘树红;李筱涵;孙志强;史晨辉;赵景民;;干扰素γ和白介素10在慢性乙型重型肝炎中的变化[J];现代生物医学进展;2011年09期
6 张夏华,吴广通,周萍;泛昔洛韦联合干扰素γ抗HBV的临床疗效观察[J];中国现代应用药学;2005年03期
7 吴广通;张夏华;王小霞;;泛昔洛韦联合干扰素γ对HBV-DNA的影响[J];中国药业;2008年22期
8 薛建亚,秦一中,韩絮琳,万谟彬,沈茜,傅益平;植物血凝素诱导肝炎患者外周血单个核细胞分泌白细胞介素10和干扰素γ的检测[J];中华传染病杂志;2000年04期
9 王晓杰,杨艳杰,富英群,朱宽胜;应用干扰素γ控制尖锐湿疣复发的疗效观察[J];中国艾滋病性病;2003年03期
10 金寿青,王剑虹;激光联合局部封闭干扰素γ治疗尖锐湿疣65例[J];华北煤炭医学院学报;2001年04期
相关会议论文 前1条
1 李征;;干扰素γ局封加激光联合治疗尖锐湿疣359例临床观察[A];2003中国中西医结合皮肤性病学术会议论文汇编[C];2003年
,本文编号:1524659
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/1524659.html